IV lidocaine
ApprovedSmall molecule
IV lidocaine is one of 109 small molecule programs targeting Hernia. It is currently in Approved.
6
Indications
12
Total Trials
4
Active Trials
108
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
230 competitors in Cesarean Section
#DrugCompanyPhaseTrials
1IV lidocaine
WWake Forest University Health Sciences
Approved
Marcaine
IInnocoll
Preclinical
Pitocin
RRetrophin
Preclinical
Naropin
FFresenius Kabi Oncology Ltd.
Preclinical
Neo-Synephrine
EExela Pharma Sciences, LLC.
Preclinical
Proamatine
TakedaPreclinical
Duragesic
CCephalon
Preclinical
Xylocaine
MMEDRx USA, Inc.
Preclinical
Versed
CConrado Roberto Hoffmann Filho
Preclinical
Catapres
Boehringer IngelheimPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Hemodynamic Response1 trial
Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation
Completed·—··NCT06107543·94 enrolled
Tinnitus1 trial
An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus
Recruiting·—·Phase 1·NCT04192773·40 enrolled
Cesarean Section1 trial
Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Cesarean Section
Unknown status·—·N/A·NCT04505644·180 enrolled
7 more indications
Erector Spinae Plane Block1 trial
Endometriosis1 trial
Effects of Intravenous Lidocaine on Endometriosis Pain
Completed·—·N/A·NCT01968694·20 enrolled
Liposomal Bupivacaine1 trial
Intravenous Lidocaine1 trial
Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Laparoscopy
Unknown status·—·N/A·NCT04506034·150 enrolled
Lidocaine Infusion1 trial
Intraoperative Lidocaine Infusion
Not yet recruiting·—·Phase 2/3·NCT07150481·90 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for IV lidocaine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details